TY - JOUR
T1 - Review of the clinical approach to the treatment of disruptive mood dysregulation disorder
AU - Hendrickson, Brian
AU - Girma, Mahlet
AU - Miller, Leslie
N1 - Funding Information:
Dr. Miller receives grant funding from PCORI and Once Upon a Time Foundation.
Publisher Copyright:
© 2019, © 2019 Institute of Psychiatry and Johns Hopkins University.
PY - 2020/4/2
Y1 - 2020/4/2
N2 - Though a decade of research led to the creation of disruptive mood dysregulation disorder (DMDD), it was not until the 2013 publication of the DSM-5 that DMDD became an official diagnosis. The conception of DMDD was largely due to increasing rates of paediatric bipolar disorder (PBD) diagnoses, which significantly impacted treatment for these youth. The core symptoms of DMDD include persistent irritability and recurrent outbursts; the absence of a previous diagnostic category for youth experiencing these symptoms may have led to the over diagnosis of PBD. Due to the chronicity of symptoms, these youth are impaired in multiple areas of functioning. This article will present background information about DMDD, discuss clinical assessment strategies including scales for measuring irritability and aggression, and review pharmacologic and psychosocial treatments for youth with DMDD and clinical phenotypes similar to DMDD.
AB - Though a decade of research led to the creation of disruptive mood dysregulation disorder (DMDD), it was not until the 2013 publication of the DSM-5 that DMDD became an official diagnosis. The conception of DMDD was largely due to increasing rates of paediatric bipolar disorder (PBD) diagnoses, which significantly impacted treatment for these youth. The core symptoms of DMDD include persistent irritability and recurrent outbursts; the absence of a previous diagnostic category for youth experiencing these symptoms may have led to the over diagnosis of PBD. Due to the chronicity of symptoms, these youth are impaired in multiple areas of functioning. This article will present background information about DMDD, discuss clinical assessment strategies including scales for measuring irritability and aggression, and review pharmacologic and psychosocial treatments for youth with DMDD and clinical phenotypes similar to DMDD.
KW - Disruptive mood dysregulation disorder
KW - assessment
KW - child and adolescent mental health
KW - mood disorder
KW - pharmacologic treatment
KW - psychosocial treatment
UR - http://www.scopus.com/inward/record.url?scp=85076455729&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076455729&partnerID=8YFLogxK
U2 - 10.1080/09540261.2019.1688260
DO - 10.1080/09540261.2019.1688260
M3 - Review article
C2 - 31775528
AN - SCOPUS:85076455729
SN - 0954-0261
VL - 32
SP - 202
EP - 211
JO - International Review of Psychiatry
JF - International Review of Psychiatry
IS - 3
ER -